Skip to main content

Articles By John Swope

Hip

Need for Pre-operative Hyperglycemia Testing Prior to Total Joint Replacement

By John Swope
28 April 2020

JAMA reports on a large Medicare cohort study showing that amongst patients undergoing total joint replacement (TJR), preoperative HbA1c testing was performed in 26% to 43% of patients with diabetes and in only 5% of those without diabetes. Importantly research has shown that an elevated HbA1c level is associated with postoperative complications.

Read Article
Hands with PSA

Updates on Psoriatic Arthritis at ACR 2018

Dr. Philip Gardiner
05 March 2020

I think 2018 was the year that belonged to psoriatic arthritis (although some may argue in favor of immune conditions induced by Checkpoint inhibitors). Many years ago the late Professor Verna Wright in Leeds (UK) was a lone voice for many years describing the clinical subtypes of Psoriatic arthritis as something distinctive from rheumatoid arthritis. For a long time we thought that the treatments for PsA were just the same as RA since we were treating the same problem of synovitis.

Read Article
Elizabeth Pope

Methotrexate and the Risk of Lung Disease

Kathryn Dao, MD
25 February 2020

Rheumatology has a comprehensive overview of methotrexate (MTX) and the risk of lung injury, MTX-related pneumonitis and interstitial lung disease (RA-ILD) with rheumatoid arthritis (RA).  Past reports suggest the frequence of MTX-pneumonitis to be between 0.3 and 11.6%; recent studies s

Read Article

Pregnancy Outcomes Improve in Lupus

By John Swope
24 February 2020

Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve.

Read Article
ACR Meeting Day 4

ACR 2018 - Day 3 Report

By John Swope
09 January 2020

Highlights from Tuesday, day 3 of the ACR Annual meeting in Chicago, included the PEXIVAS Study, ACR Reproductive Health Draft Guidelines, and a Proof of concept study

Read Article
Meeting table with mics

ACR 2018 - Day 1 Report

By John Swope
11 October 2019

Highlights from Tuesday and Wednesday (days 3 and 4) from the ACR annual meeting include: the important and impactful abstracts covered by the Rheumatology Roundup session; upadacitinib clinical trials; and the baricitinib CV and VTE safety analysis.

Read Article
Coupe

FEAR: A Perception of Fact In Spite of the Fiction

By John Swope
19 September 2019

Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve.

Read Article
IL-2 inhibitor

Low Dose IL-2 Effective in Lupus

By John Swope
18 September 2019

A double-blind, placebo-controlled clinical trial of low-dose IL-2 in patients with systemic lupus erythematosus (SLE) has shown that low-dose IL-2 induced was clinically effective while expandng regulatory T cells and NK cells, which may benefit immune homeostasis in SLE patients.

Read Article
Restaurant

The 16th Annual La Paulee

By John Swope
21 October 2018

La Paulee is traditionally the party/feast after harvest and a time when hard work is rewarded with food, fun, and wine. And so it was that evening; after better understanding genes, cytokines, and pathology it was time to have a good time with friends, old and new.

Read Article
Muscle

Update on Myositis

By John Swope
20 September 2018

The ACR/ARHP 2018 national meeting in Chicago presented us with opportunities to learn more about inflammatory myositis. A particularly interesting lecture was HOT topics in myositis. There were a few abstracts on MDA-5 related disease and a few on new or repurposed medications for dermatomyositis which will be covered here.

Read Article
×